Home / Health / CDC releases revised guidelines for the prevention and treatment of anthrax

CDC releases revised guidelines for the prevention and treatment of anthrax

Anthrax continues to occur in certain places around the world, with an estimated 20,000–100,000 cases occurring annually. Bacillus anthracis is considered the most likely bioweapon to be used during a bioterrorist event. To help protect the public’s health, CDC has published updated recommendations for the prevention and treatment of anthrax.

The guidance includes best practices for the clinical management of anthrax, including anthrax meningitis. The updated recommendations include an expanded list of alternate antimicrobial drugs to use if first-line drugs are depleted following a bioterrorism event, ineffective against a genetically engineered resistant B. anthracis strain, or not tolerated by some people.

Clinicians and public health professionals should use these recommendations to prevent and treat anthrax and to improve emergency preparedness efforts for bioterrorism events involving a wide-area release of B. anthracis into the air.

About Gladys Johnson

Gladys Johnson The Publisher/Editor-In-Chief Global Business Drive Phone: +13465619347 Email: info@globalbusinessdrive.com gladysjohnsonmedia@gmail.com gladys@globalbusinessdrive.com globalbusinessdrive@gmail.com

Check Also

Seplat Energy Named Daily Independent’s Indigenous Oil & Gas Company of the Year

  Seplat Energy PLC, a leading Nigerian independent energy company listed on both the Nigerian …

Leave a Reply

Your email address will not be published. Required fields are marked *

pub-5127930111112337, DIRECT, f08c47fec0942fa0